Pacs Group Stock Performance
| PACS Stock | 34.97 0.17 0.48% |
PACS holds a performance score of 16 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -1.42, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning PACS are expected to decrease by larger amounts. On the other hand, during market turmoil, PACS is expected to outperform it. Use PACS Group value at risk, and the relationship between the jensen alpha and skewness , to analyze future returns on PACS Group.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in PACS Group are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating fundamental indicators, PACS unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.48) | Five Day Return (11.18) | Year To Date Return (11.49) | Ten Year Return 52.04 | All Time Return 52.04 |
1 | Nasdaq Turns Higher NY Manufacturing Activity Surges In November | 11/17/2025 |
2 | Disposition of 159556 shares by Mitchell John Todd of PACS Group, at 29.8853 subject to Rule 16b-3 | 11/24/2025 |
3 | Insider Selling PACS Group Insider Sells 159,556 Shares of Stock | 11/26/2025 |
4 | PACS Group stock rating reinstated as Overweight by JPMorgan - Investing.com | 12/16/2025 |
5 | Acquisition by Jason Murray of 200000 shares of PACS subject to Rule 16b-3 | 12/17/2025 |
6 | Acquisition by Millard Jacqueline of 4399 shares of PACS subject to Rule 16b-3 | 12/19/2025 |
7 | PACS Group stock hits 52-week high at .42 USD By Investing.com - Investing.com Nigeria | 12/30/2025 |
8 | PACS Group Inc stock hits 52-week high at 41.18 USD - Investing.com Nigeria | 01/08/2026 |
9 | PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 515 p.m., Pacific Time | 01/12/2026 |
10 | Disposition of 20082 shares by Jason Murray of PACS at .49 subject to Rule 16b-3 | 01/15/2026 |
11 | PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities | 01/20/2026 |
12 | Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 | 01/22/2026 |
| Begin Period Cash Flow | 118.7 M | |
| Total Cashflows From Investing Activities | -442.7 M |
PACS Relative Risk vs. Return Landscape
If you would invest 1,260 in PACS Group on October 26, 2025 and sell it today you would earn a total of 2,237 from holding PACS Group or generate 177.54% return on investment over 90 days. PACS Group is currently generating 2.0804% in daily expected returns and assumes 10.0699% risk (volatility on return distribution) over the 90 days horizon. In different words, 90% of stocks are less volatile than PACS, and 59% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PACS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PACS's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PACS Group, and traders can use it to determine the average amount a PACS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average PACS is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PACS by adding it to a well-diversified portfolio.
PACS Fundamentals Growth
PACS Stock prices reflect investors' perceptions of the future prospects and financial health of PACS, and PACS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PACS Stock performance.
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.0007 % | ||||
| Current Valuation | 8.61 B | ||||
| Shares Outstanding | 155.18 M | ||||
| Price To Book | 6.32 X | ||||
| Price To Sales | 1.06 X | ||||
| Revenue | 4.09 B | ||||
| Gross Profit | 519.14 M | ||||
| EBITDA | 186.7 M | ||||
| Net Income | 55.76 M | ||||
| Total Debt | 3.5 B | ||||
| Book Value Per Share | 3.75 X | ||||
| Cash Flow From Operations | 367.34 M | ||||
| Earnings Per Share | 0.61 X | ||||
| Market Capitalization | 2.24 B | ||||
| Total Asset | 5.24 B | ||||
| Retained Earnings | 118.04 M | ||||
| Working Capital | (40.17 M) | ||||
About PACS Performance
Assessing PACS's fundamental ratios provides investors with valuable insights into PACS's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the PACS is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.09 | 0.09 |
Things to note about PACS Group performance evaluation
Checking the ongoing alerts about PACS for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PACS Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PACS Group is way too risky over 90 days horizon | |
| PACS Group appears to be risky and price may revert if volatility continues | |
| About 72.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 |
- Analyzing PACS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PACS's stock is overvalued or undervalued compared to its peers.
- Examining PACS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PACS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PACS's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PACS's stock. These opinions can provide insight into PACS's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for PACS Stock Analysis
When running PACS's price analysis, check to measure PACS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS is operating at the current time. Most of PACS's value examination focuses on studying past and present price action to predict the probability of PACS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS's price. Additionally, you may evaluate how the addition of PACS to your portfolios can decrease your overall portfolio volatility.